Randy A Vince Jr
Overview
Explore the profile of Randy A Vince Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arenas-Gallo C, Michie M, Jones N, Pronovost P, Vince Jr R
N Engl J Med
. 2024 Jul;
391(5):468-474.
PMID: 39083779
No abstract available.
2.
Vince Jr R, Sun H, Singhal U, Schumacher F, Trapl E, Rose J, et al.
Eur Urol Oncol
. 2024 May;
8(1):47-55.
PMID: 38734542
Background And Objective: Polygenic risk scores (PRSs) have been developed to identify men with the highest risk of prostate cancer. Our aim was to compare the performance of 16 PRSs...
3.
Vince Jr R, Arenas-Gallo C, Pronovost P
Popul Health Manag
. 2024 Apr;
27(3):218-220.
PMID: 38572794
No abstract available.
4.
Appleton A, Black K, Sellke N, Washington 3rd S, Does S, Rhodes S, et al.
Urology
. 2024 Feb;
187:39-45.
PMID: 38354914
Objective: To project the proportion of the urology workforce that is from under-represented in medicine (URiM) groups between 2021-2061. Methods: Demographic data were obtained from AUA Census and ACGME Data...
5.
Yu J, Sun Y, Jia A, Vince Jr R, Shoag J, Zaorsky N, et al.
JAMA Oncol
. 2023 Oct;
9(12):1696-1701.
PMID: 37796479
Importance: Randomized clinical trials have demonstrated the noninferiority of shorter radiotherapy (RT) courses (termed hypofractionation) compared with longer RT courses in patients with localized prostate cancer. Although shorter courses are...
6.
Baydoun A, Jia A, Zaorsky N, Kashani R, Rao S, Shoag J, et al.
Prostate Cancer Prostatic Dis
. 2023 Jun;
27(1):37-45.
PMID: 37296271
Artificial intelligence (AI) applications have enabled remarkable advancements in healthcare delivery. These AI tools are often aimed to improve accuracy and efficiency of histopathology assessment and diagnostic imaging interpretation, risk...
7.
Vince Jr R, Jiang R, Bank M, Quarles J, Patel M, Sun Y, et al.
JAMA Netw Open
. 2023 Jan;
6(1):e2250416.
PMID: 36630135
Importance: As the field of medicine strives for equity in care, research showing the association of social determinants of health (SDOH) with poorer health care outcomes is needed to better...
8.
Basourakos S, Gulati R, Vince Jr R, Spratt D, Lewicki P, Hill A, et al.
NEJM Evid
. 2022 Jun;
1(6).
PMID: 35721307
Background: Prostate-specific antigen screening has profoundly affected the epidemiology of prostate cancer in the United States. Persistent racial disparities in outcomes for Black men warrant re-examination of the harms of...
9.
Vince Jr R, Sun Y, Mahal B, Ginsburg K, George A, Cher M, et al.
Eur Urol
. 2022 Jun;
83(4):307-310.
PMID: 35688664
Active surveillance (AS) is recommended as a management option for men with favorable-risk (low risk and favorable intermediate risk) prostate cancer; however, national rates remain low. The Michigan Urological Surgery...
10.
Vince Jr R, Eyrich N, Mahal B, Stensland K, Schaeffer E, Spratt D
J Clin Oncol
. 2021 Oct;
40(1):8-11.
PMID: 34694897
No abstract available.